Microbot Medical
MBOT
28 hedge funds and large institutions have $2.01M invested in Microbot Medical in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
8% more funds holding
Funds holding: 26 → 28 (+2)
0% less ownership
Funds ownership: 0.34% → 0.34% (-0%)
4% less capital invested
Capital invested by funds: $2.1M → $2.01M (-$91K)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$161K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$79.1K |
| 3 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
+$45.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.9K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$46K |
| 2 |
Millennium Management
New York
|
-$21K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$15.3K |
| 4 |
Bank of New York Mellon
New York
|
-$15K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.3K |
MBOT Hedge Fund Activity: Q4 2017 in Review
28 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2017, worth a combined $2.01M — down 4.3% from $2.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBOT positions and 4 closed out — a net gain of 2 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $161K. The largest seller was Squarepoint, exiting entirely with an estimated $46K sold.
- 28 institutional investors held Microbot Medical (MBOT) as of Q4 2017, up from 26 in Q3 2017.
- Funds reported $2.01M of Microbot Medical stock for Q4 2017, down 4.3% quarter-over-quarter.
- 6 funds opened new Microbot Medical positions in Q4 2017 and 4 closed out, a net change of +2 holders.
- The largest Microbot Medical buyer in Q4 2017 was Vanguard Group, an estimated $161K added.
- The largest Microbot Medical seller in Q4 2017 was Squarepoint, an estimated $46K sold.
Based on aggregated 13F filings for Q4 2017.